AGM Statement

Oxford Instruments PLC
25 September 2007


25 September 2007


                             Oxford Instruments plc
                         Chairman's AGM Statement 2007



Oxford Instruments plc, the high technology tools and systems company, is
holding its Annual General Meeting today at which the Chairman, Nigel Keen, will
make the following statement:


Two years ago Oxford Instruments embarked on a strategy to reposition the
business towards future growth markets such as those benefiting from nano
technology and bioscience. The industries using these technologies show strong
intrinsic growth. This, coupled with an increasingly commercial approach across
the Group is proving to be a successful growth engine for us. We provide
innovative systems solutions to help our customers in fields such as
pharmaceutical research and environmental monitoring.


In June we reported on the first full year of this strategy. We achieved 
progress in line with our plan to double the size of the business in five years 
and improve EBIT margins by ten percentage points.


Last year we met our targets through organic growth. This year, acquisitions
will also contribute. To date we have acquired two companies, Worldwide
Analytical Systems (WAS) and Vericold, both based in Germany. WAS will
significantly strengthen and complement the existing product range of industrial
spectrometers produced by Oxford Instruments Industrial Analysis business unit.
Vericold will give our Nanoscience business unit access to growth segments
outside its traditional academic research markets including quantum computing
and airport security. The integration of both acquisitions is proceeding
according to plan.


Our turnover to date this year is ahead of the same period last year. This has
been achieved despite, as previously reported in our Interim Management
Statement last month, the slowdown in demand for new MRI machines in North
America and a reduction in sales relating to hazardous substances (RoHS)
legislation. The impact of these factors and unfavourable foreign exchange rates
have been offset by growth across other parts of our business. This demonstrates
the continuing strength of our core markets and we look forward to new products
coming on stream in both our Analytical and Superconductivity businesses in the
second half of the year. As a result the Board is confident that the performance
for the year will meet its expectations.



Enquiries:

Oxford Instruments plc                                         Tel: [phone]
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director

Hogarth Partnership Limited                                   Tel: [phone]

Rachel Hirst / Andrew Jaques / Ian Payne



Notes to Editors


Oxford Instruments designs, supplies and supports high-technology tools,
processes and solutions with a focus on physical science, bioscience,
environmental and industrial research and applications. It provides solutions
needed to advance fundamental nanoscience research and its transfer into
commercial nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 40 years, and its
strategy is to effect the successful commercialisation of these ideas by
bringing them to market in a timely and customer-focused fashion.


The first technology business to be spun out from Oxford University over forty
years ago, Oxford Instruments is now a global company with over 1,300 staff
worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to
be the leading provider of new generation tools and systems for the Physical
Science and Bioscience sectors.


This involves the combination of core technologies in areas such as low
temperature and high magnetic field environments, Nuclear Magnetic Resonance,
X-ray electron and optical based metrology, and advanced growth, deposition and
etching. Our products, expertise, and ideas address global issues such as
energy, environment, terrorism and health and are part of the next generation of
telecommunications, energy products, environmental measures, security devices,
drug discovery and medical advances.





                      This information is provided by RNS
            The company news service from the London Stock Exchange
                 UAR